These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


857 related items for PubMed ID: 19668233

  • 1. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, Chen C.
    Oncogene; 2009 Oct 22; 28(42):3702-13. PubMed ID: 19668233
    [Abstract] [Full Text] [Related]

  • 2. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C, Zhou Y, Zhou Z, Sun X, Otto KB, Uht RM, Dong JT.
    Gene; 2004 Apr 14; 330():133-42. PubMed ID: 15087132
    [Abstract] [Full Text] [Related]

  • 3. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
    Kagan BL, Henke RT, Cabal-Manzano R, Stoica GE, Nguyen Q, Wellstein A, Riegel AT.
    Cancer Res; 2003 Apr 01; 63(7):1696-705. PubMed ID: 12670924
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
    Mori A, Moser C, Lang SA, Hackl C, Gottfried E, Kreutz M, Schlitt HJ, Geissler EK, Stoeltzing O.
    Mol Cancer Res; 2009 Aug 01; 7(8):1390-8. PubMed ID: 19671674
    [Abstract] [Full Text] [Related]

  • 5. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.
    Liu R, Zheng HQ, Zhou Z, Dong JT, Chen C.
    J Biol Chem; 2009 Jun 19; 284(25):16791-16798. PubMed ID: 19411256
    [Abstract] [Full Text] [Related]

  • 6. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.
    Tong D, Czerwenka K, Heinze G, Ryffel M, Schuster E, Witt A, Leodolter S, Zeillinger R.
    Clin Cancer Res; 2006 Apr 15; 12(8):2442-8. PubMed ID: 16638850
    [Abstract] [Full Text] [Related]

  • 7. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
    Lee MY, Moon JS, Park SW, Koh YK, Ahn YH, Kim KS.
    Biochem J; 2009 Jan 01; 417(1):313-22. PubMed ID: 18774944
    [Abstract] [Full Text] [Related]

  • 8. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T.
    Biochem J; 2003 Oct 01; 375(Pt 1):199-205. PubMed ID: 12841847
    [Abstract] [Full Text] [Related]

  • 9. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer.
    Chen C, Bhalala HV, Qiao H, Dong JT.
    Oncogene; 2002 Sep 26; 21(43):6567-72. PubMed ID: 12242654
    [Abstract] [Full Text] [Related]

  • 10. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
    Zhi X, Zhao D, Zhou Z, Liu R, Chen C.
    Am J Pathol; 2012 Jun 26; 180(6):2452-61. PubMed ID: 22632819
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM, Brokken LJ, Härkönen PL.
    Exp Cell Res; 2010 Mar 10; 316(5):800-12. PubMed ID: 19962979
    [Abstract] [Full Text] [Related]

  • 12. Krüppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines.
    Zhang G, Zhu H, Wang Y, Yang S, Liu M, Zhang W, Quan L, Bai J, Liu Z, Xu N.
    Biol Chem; 2009 Mar 10; 390(5-6):463-9. PubMed ID: 19361279
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
    Seifeddine R, Dreiem A, Blanc E, Fulchignoni-Lataud MC, Le Frère Belda MA, Lecuru F, Mayi TH, Mazure N, Favaudon V, Massaad C, Barouki R, Massaad-Massade L.
    Cancer Res; 2008 Apr 01; 68(7):2158-65. PubMed ID: 18381421
    [Abstract] [Full Text] [Related]

  • 14. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N, Hill AD, Young LS.
    J Mol Endocrinol; 2006 Dec 01; 37(3):377-90. PubMed ID: 17170079
    [Abstract] [Full Text] [Related]

  • 15. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation.
    Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K, Nishimura G, Maemura K, Yamauchi T, Kubota N, Suzuki R, Kitamura T, Akira S, Kadowaki T, Nagai R.
    Cell Metab; 2005 Jan 01; 1(1):27-39. PubMed ID: 16054042
    [Abstract] [Full Text] [Related]

  • 16. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN, Yip GW, Tan PH, Thike AA, Matsumoto K, Tsujimoto M, Bay BH.
    Int J Oncol; 2010 Aug 01; 37(2):483-92. PubMed ID: 20596676
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M.
    Oncogene; 2009 Oct 22; 28(42):3689-701. PubMed ID: 19668225
    [Abstract] [Full Text] [Related]

  • 18. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA.
    Mol Cancer Res; 2004 Nov 22; 2(11):653-61. PubMed ID: 15561781
    [Abstract] [Full Text] [Related]

  • 19. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y, Shirakata Y, Hashimoto K, Higashiyama S.
    Oncogene; 2007 Jan 18; 26(3):339-48. PubMed ID: 16862184
    [Abstract] [Full Text] [Related]

  • 20. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.
    Takagi K, Miki Y, Onodera Y, Nakamura Y, Ishida T, Watanabe M, Inoue S, Sasano H, Suzuki T.
    Endocr Relat Cancer; 2012 Dec 18; 19(6):741-50. PubMed ID: 22936544
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 43.